FDA approves Wegovy pill for weight loss
The Food and Drug Administration has approved a pill version of the weight-loss drug Wegovy.
Watch CBS News
The Food and Drug Administration has approved a pill version of the weight-loss drug Wegovy.
The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month in some cases, officials said.
A one-month supply of Ozempic and Wegovy will now cost $499 out of pocket for Costco shoppers.
Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.
According to the arrest documents, two of the drugs found in the lollipops are the active ingredients of popular weight-loss medications Ozempic, Wegovy and Zepbound.
The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.
CBS News Miami investigated the financial hurdles surrounding these medications and explores alternatives that may offer a more affordable path to weight loss.
Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare and Medicaid under a rule the Biden administration has proposed.
This may be the first Thanksgiving for millions of Americans who are on GLP-1 agonists like Ozempic, Zepbound or Wegovy.
Record demand for Ozempic, Wegovy and other weight loss drugs is fueling a surge of dangerous knockoffs.
High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the meantime, a market for cheaper, compounded drugs thrives.
Novo Nordisk and Lilly can't keep up with demand for their weight loss drugs such as Ozempic, Wegovy and Mounjaro. But they object to specialty pharmacies making their own cheaper versions to fill the gap — providing as much as 30% of those drugs sold in the U.S.
Vital Pursuit will include whole-grain bowls, protein pasta, sandwich melts and gluten-free options.
A joint investigation by Digital Citizens Alliance and Coalition for a Safer Web found dozens of TikTok profiles offering to ship weight loss drugs for lower prices and without a prescription. In nearly every situation, it was a scam.
WeightWatchers program aims to help members maintain healthy habits while taking anti-obesity drugs like Ozempic and Wegovy.
A clinical trial found Wegovy reduced the risk of heart attack, stroke, and heart-related death by 20 percent in people with cardiovascular disease.
While Ozempic's interaction with the reward centers in our brain could help explain this, Dr. Tamika Henry, founder of Unlimited Health Institute, says more studies are needed.
